ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2026
Who Enrolls After Referral to Virtual Pulmonary Rehabilitation? A Descriptive Comparison.
Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multidisciplinary management of chronic obstructive pulmonary disease (COPD) that combines pharmacotherapy, patient education, and pulmonary rehabilitation (PR) is recommended to optimize outcomes. Virtual pulmonary rehabilitation (VPR) offers a novel approach to expanding access to care by addressing geographic barriers. Methods: We conducted a retrospective cohort study involving patients with COPD who were referred to a VPR program from the pulmonary clinic of a single academic center. Demographic information was collected. The Social Vulnerability Index (SVI) was determined and the mean distance to the nearest in-person PR program. The primary objective was to describe the characteristics of patients referred to VPR who enrolled in the program compared with those who did not. The secondary objectives were to understand reasons patients choose not to enroll in VPR and to evaluate changes in clinical outcomes before and after participation in the program, with comparisons across SVI. Results: A total of 278 patients were referred, of whom 63 (22.7%) either completed or were actively participating in the program. Of the patients referred, 23 (8.3%) were ineligible, and another 45 (16.2%) declined enrollment. The average age of enrolled patients was 76.7 (8.4) years, and most patients were female (N=38, 60.3%). The average SVI was 0.53 (medium social vulnerability). The average distance to an in-person PR center was 12.6 miles. There were no significant differences in SVI, distance to PR center, language, or race between enrolled and nonenrolled patients. Conclusion: VPR may serve as an effective, accessible option for patients with COPD to improve functional and patient-centered outcomes. However, despite mitigating geographic barriers through VPR, obstacles to expanding PR program enrollment persist.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.